Skip to main content
. 2021 Jul 5;8:684859. doi: 10.3389/fnut.2021.684859

Table 5.

Subgroup analyses of the associations between tomato or lycopene intake and total mortality were performed based on sex, smoking status, and BMI.

Variables Group Raw tomato P for interaction Tomato catsup P for interaction Lycopene P for interaction
Male Q1 Reference group >0.05 >0.05 >0.05
Q2 0.95 (0.91–1.00), p = 0.056 0.97 (0.91–1.03), p = 0.296 0.95 (0.90–1.01), p = 0.097
Q3 0.94 (0.89–0.99), p = 0.021 0.92 (0.87–0.98), p = 0.006 0.93 (0.88–0.99), p = 0.017
Q4 0.90 (0.86–0.96), p < 0.001 0.94 (0.90–0.99), p = 0.023 0.91 (0.86–0.97), p = 0.002
Q5 0.95 (0.90–1.00), p = 0.059 0.93 (0.88–0.98), p = 0.007 1.01 (0.95–1.08), p = 0.671
Female Q1 Reference group
Q2 0.97 (0.90–1.03), p = 0.308 0.92 (0.87–0.98), p = 0.004 0.88 (0.83–0.94), p < 0.001
Q3 0.91 (0.85–0.97), p = 0.004 0.89 (0.84–0.94), p < 0.001 0.87 (0.81–0.93), p < 0.001
Q4 0.92 (0.86–0.99), p = 0.017 0.93 (0.85–1.00), p = 0.064 0.85 (0.79–0.91), p < 0.001
Q5 0.96 (0.89–1.03), p = 0.235 0.94 (0.88–1.01), p = 0.110 0.95 (0.87–1.03), p = 0.192
Never smokers Q1 Reference group >0.05 0.035 >0.05
Q2 0.93 (0.87–0.99), p = 0.027 0.93 (0.87–0.99), p = 0.031 0.88 (0.83–0.94), p < 0.001
Q3 0.89 (0.83–0.95), p < 0.001 0.91 (0.85–0.97), p = 0.003 0.87 (0.81–0.93), p < 0.001
Q4 0.88 (0.82–0.94), p < 0.001 0.93 (0.87–1.00), p = 0.051 0.85 (0.79–0.92), p < 0.001
Q5 0.93 (0.87–1.01), p = 0.075 0.95 (0.89–1.02), p = 0.132 0.94 (0.87–1.02), p = 0.148
Current smokers Q1 Reference group
Q2 1.05 (0.96–1.16), p = 0.296 1.05 (0.94–1.16), p = 0.396 0.93 (0.84–1.03), p = 0.168
Q3 0.96 (0.86–1.07), p = 0.441 0.94 (0.84–1.04), p = 0.223 0.92 (0.82–1.03), p = 0.133
Q4 1.03 (0.92–1.14), p = 0.609 0.89 (0.80–0.99), p = 0.035 0.89 (0.79–1.00), p = 0.046
Q5 0.97 (0.87–1.09), p = 0.668 0.98 (0.88–1.09), p = 0.713 0.95 (0.84–1.08), p = 0.463
Former smokers Q1 Reference group
Q2 0.95 (0.89–1.01), p = 0.074 0.92 (0.87–0.98), p = 0.006 0.95 (0.89–1.01), p = 0.083
Q3 0.94 (0.89–1.00), p = 0.044 0.89 (0.84–0.95), p < 0.001 0.93 (0.87–0.98), p = 0.014
Q4 0.90 (0.84–0.95), p < 0.001 0.93 (0.88–0.98), p = 0.013 0.91 (0.85–0.97), p = 0.005
Q5 0.95 (0.89–1.01), p = 0.125 0.89 (0.84–0.95), p < 0.001 1.04 (0.97–1.12), p = 0.288
BMI <25.0 kg/m2 Q1 Reference group >0.05 >0.05 >0.05
Q2 0.94 (0.88–1.01), p = 0.076 0.90 (0.84–0.96), p = 0.002 0.87 (0.82–0.93), p < 0.001
Q3 0.88 (0.82–0.94), p < 0.001 0.89 (0.84–0.96), p = 0.001 0.88 (0.82–0.94), p < 0.001
Q4 0.92 (0.85–0.98), p = 0.017 0.90 (0.84–0.97), p = 0.004 0.84 (0.77–0.90), p < 0.001
Q5 0.90 (0.83–0.97), p = 0.007 0.94 (0.87–1.01), p = 0.109 0.96 (0.88–1.05), p = 0.343
BMI ≥25.0 kg/m2 Q1 Reference group
Q2 0.97 (0.92–1.02), p = 0.220 0.97 (0.92–1.02), p = 0.265 0.95 (0.91–1.00), p = 0.069
Q3 0.95 (0.91–1.00), p = 0.053 0.92 (0.88–0.97), p = 0.002 0.93 (0.88–0.98), p = 0.008
Q4 0.91 (0.87–0.96), p < 0.001 0.96 (0.91–1.01), p = 0.087 0.92 (0.87–0.97), p = 0.004
Q5 0.98 (0.93–1.04), p = 0.490 0.95 (0.90–1.00), p = 0.037 1.03 (0.97–1.09), p = 0.336

BMI, body mass index.